ALXO

Alx Oncology Holdings Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 6/10
  • Value↓ 4/10
Alx Oncology Holdings sales and earnings growth
ALXO Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 26.36%
  • FCF Y/Y↑ 31.06%
Alx Oncology Holdings gross and profit margin trends
ALXO Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -94.61%
Alx Oncology Holdings net debt vs free cash flow
ALXO Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -62.5

Alx Oncology Holdings stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗